AXIM Balance Sheets
(Quarterly, GAAP in millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
ASSETS |
Cash & cash equivalent |
0.02 |
0.10 |
0.05 |
0.05 |
0.16 |
Security Deposit |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
Cash
& Short-term Investments |
0.03 |
0.11 |
0.06 |
0.05 |
0.17 |
Accounts receivable |
- |
- |
- |
- |
- |
Notes Receivable, Related Parties |
- |
- |
- |
- |
- |
Notes, Loans and Financing Receivable, Net, Current AC |
- |
- |
- |
- |
- |
Finite Lived License Agreements Gross Net Of Accumulated Amortization |
- |
- |
- |
- |
3.86 |
Inventories |
- |
- |
- |
- |
0.02 |
Other Current Assets |
- |
- |
- |
0.01 |
- |
Prepaid Expense, Current AS |
- |
- |
- |
0.04 |
0.07 |
Total Current Assets |
0.03 |
0.11 |
0.06 |
0.10 |
0.25 |
Equipment/Property/Plant Net |
0.07 |
0.08 |
- |
0.09 |
0.10 |
Goodwill net |
- |
- |
- |
- |
- |
Intangible Assets |
3.69 |
3.79 |
3.89 |
3.99 |
- |
Long-term investments |
- |
- |
- |
- |
- |
Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
Financial Instruments |
- |
- |
- |
- |
- |
Deferred Tax Assets, in Process Research and Development |
- |
- |
- |
- |
- |
Other Assets, Noncurrent |
0.25 |
0.27 |
0.09 |
0.02 |
4.00 |
Prepaid Expense AS |
- |
- |
- |
- |
- |
Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
Operating Lease Right Of Use Asset |
0.25 |
0.27 |
0.00 |
0.02 |
0.03 |
Total Assets |
4.04 |
4.25 |
4.04 |
4.21 |
4.48 |
LIABILITIES |
Accounts Payable and Accrued Liabilities, Current LI |
1.42 |
1.24 |
- |
- |
1.05 |
Accounts Payable and Other Accrued Liabilities |
- |
- |
1.18 |
1.32 |
- |
Derivative Liability, Current DE |
2.37 |
6.65 |
1.12 |
1.65 |
- |
Long-term Debt and Capital Lease Obligations, Current DE |
0.09 |
0.09 |
0.00 |
0.02 |
- |
Other Liabilities, Current |
0.08 |
0.07 |
2.23 |
0.03 |
2.08 |
Taxes Payable |
- |
- |
- |
- |
- |
Deferred Revenue, Current DE |
0.31 |
0.32 |
0.33 |
0.33 |
0.03 |
Discontinued Operation, Liabilities, Current |
- |
- |
- |
- |
- |
Due To First Insurance Funding |
- |
- |
- |
- |
0.05 |
Operating Lease Liability Current |
- |
- |
- |
- |
0.03 |
Due To From Sapphire Bio Sapphire Diagnostic |
- |
- |
- |
- |
- |
Current Liabilities Of Discontinued Operations |
- |
- |
- |
- |
- |
Lease Liability Obligations |
0.16 |
0.19 |
- |
- |
- |
Advances From Shareholder |
0.08 |
0.07 |
0.20 |
0.05 |
- |
Total Current Liabilities |
4.28 |
8.37 |
4.86 |
3.39 |
3.16 |
Long-term debt |
- |
- |
- |
- |
- |
Capital Lease Obligations LO |
- |
- |
- |
- |
- |
Long-term Debt Convertible |
0.02 |
0.02 |
0.01 |
1.38 |
1.32 |
Total
Long-term Debt |
0.02 |
0.02 |
0.01 |
1.38 |
1.32 |
Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
Deferred Revenue, Noncurrent DE |
- |
- |
- |
- |
0.12 |
Accrued Income Taxes, Noncurrent |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
Other liabilities, Noncurrent |
5.70 |
5.62 |
5.33 |
4.26 |
4.26 |
Convertible Note Payable Including Accrued Interest Net Of Unamortized Debt Discount |
- |
1.36 |
- |
4.26 |
- |
Total Liabilities |
10.00 |
14.00 |
10.20 |
9.04 |
8.86 |
SHAREHOLDER'S EQUITY |
Common Stock To Be Issued |
- |
- |
- |
0.14 |
- |
Common Stock Value |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
Common Stock, Held by Subsidiary Share, Subscribed but Unissued, Subscriptions Receivable |
- |
- |
-0.04 |
-0.05 |
- |
Additional Paid In Capital Common Stock |
64.30 |
60.84 |
60.75 |
59.19 |
58.75 |
Retained Earnings / Accumulated Deficit |
-70.28 |
-70.61 |
-66.89 |
-64.13 |
-63.23 |
Other Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.07 |
Common Stockholder's Equity |
-5.96 |
-9.75 |
-6.16 |
-4.83 |
-4.38 |
Preferred Stockholder's Equity |
0.00 |
- |
0.00 |
- |
0.00 |
Noncontrolling interests & other |
- |
- |
- |
- |
- |
Total
Stockholder's Equity |
-5.96 |
-9.75 |
-6.16 |
-4.83 |
-4.38 |
Liabilities & Stockholder's
Equity |
4.04 |
4.25 |
4.04 |
4.21 |
4.48 |